Skip to main content
. 2021 Mar 1;11(3):837–848.

Figure 4.

Figure 4

Kaplan-Meier curves, expression level and bioinformatic analyze of tsRNA-ValTAC-41 in serum and tissue of PDAC patients. A. Kaplan-Meier curves estimating the longer overall survival (OS) in patients with lower tsRNA-ValTAC-41 serum level. B. tsRNA-ValTAC-41 expression in serum was identically associated with AJCC grade I/II vs grade III/IV. C. The expression level of tsRNA-ValTAC-41 in tumor tissues and adjacent normal tissues. D. tsRNA-ValTAC-41 expression in tissue of PDAC patients was also associated with AJCC grade I/II vs grade III/IV. (P value of student t-test: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). E. GO enrichment analyzing in target genes of tsRNA-ValTAC-41.